Treatment patterns, risk factor control and functional capacity in patients with cardiovascular and chronic kidney disease in the cardiac rehabilitation setting

被引:13
|
作者
Voeller, Heinz [1 ,2 ]
Gitt, Anselm [3 ]
Jannowitz, Christina [4 ]
Karoff, Marthin [5 ]
Karmann, Barbara [4 ]
Pittrow, David [6 ]
Reibis, Rona [1 ,7 ]
Hildemann, Steven [4 ,8 ]
机构
[1] Klin See, Dept Cardiol, Rudersdorf, Germany
[2] Univ Potsdam, Rehabil Res Ctr, D-14469 Potsdam, Germany
[3] Heidelberg Univ, Inst Herzinfarktforsch, D-69115 Heidelberg, Germany
[4] MSD Sharp & Dohme GmbH, Med Affairs & Klin Forsch, Haar, Germany
[5] Klin Univ Witten Herdecke, Klin Konigsfeld Deutsch Rentenversicherung Westfa, Witten, Germany
[6] Tech Univ Dresden, Fac Med, Inst Clin Pharmacol, Dresden, Germany
[7] Cardiol Outpatient Clin, Potsdam, Germany
[8] Univ Herzzentrum Freiburg Bad Krozingen, Klin Kardiol & Angiol 1, Bad Krozingen, Germany
关键词
Cardiac rehabilitation; registry; chronic kidney disease; glomerular filtration rate; dyslipidemia; control rates; risk factor; lipids; MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; RENAL-FUNCTION; PREVALENCE; HEART; ASSOCIATION; CHOLESTEROL; EXERCISE;
D O I
10.1177/2047487313482285
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Chronic kidney disease (CKD) is a frequent comorbidity among elderly patients and those with cardiovascular disease. CKD carries prognostic relevance. We aimed to describe patient characteristics, risk factor management and control status of patients in cardiac rehabilitation (CR), differentiated by presence or absence of CKD. Design and methods: Data from 92,071 inpatients with adequate information to calculate glomerular filtration rate (GFR) based on the Cockcroft-Gault formula were analyzed at the beginning and the end of a 3-week CR stay. CKD was defined as estimated GFR <60 ml/min/1.73 m(2). Results: Compared with non-CKD patients, CKD patients were significantly older (72.0 versus 58.0 years) and more often had diabetes mellitus, arterial hypertension, and atherothrombotic manifestations (previous stroke, peripheral arterial disease), but fewer were current or previous smokers had a CHD family history. Exercise capacity was much lower in CKD (59 vs. 92Watts). Fewer patients with CKD were treated with percutaneous coronary intervention (PCI), but more had coronary artery bypass graft (CABG) surgery. Patients with CKD compared with non-CKD less frequently received statins, acetylsalicylic acid (ASA), clopidogrel, beta blockers, and angiotensin converting enzyme (ACE) inhibitors, and more frequently received angiotensin receptor blockers, insulin and oral anticoagulants. In CKD, mean low density lipoprotein cholesterol (LDL-C), total cholesterol, and high density lipoprotein cholesterol (HDL-C) were slightly higher at baseline, while triglycerides were substantially lower. This lipid pattern did not change at the discharge visit, but overall control rates for all described parameters (with the exception of HDL-C) were improved substantially. At discharge, systolic blood pressure (BP) was higher in CKD (124 versus 121 mmHg) and diastolic BP was lower (72 versus 74 mmHg). At discharge, 68.7% of CKD versus 71.9% of non-CKD patients had LDL-C <100 mg/dl. Physical fitness on exercise testing improved substantially in both groups. When the Modification of Diet in Renal Disease (MDRD) formula was used for CKD classification, there was no clinically relevant change in these results. Conclusion: Within a short period of 3-4 weeks, CR led to substantial improvements in key risk factors such as lipid profile, blood pressure, and physical fitness for all patients, even if CKD was present.
引用
收藏
页码:1125 / 1133
页数:9
相关论文
共 50 条
  • [31] Cardiovascular disease risk factors in chronic kidney disease: Overall burden and rates of treatment and control
    Parikh, NI
    Hwang, SJ
    Larson, MG
    Meigs, JB
    Levy, D
    Fox, CS
    CIRCULATION, 2006, 113 (08) : E328 - E328
  • [32] Cardiovascular disease risk factors in chronic kidney disease - Overall burden and rates of treatment and control
    Parikh, Nisha I.
    Hwang, Shih-Jen
    Larson, Martin G.
    Meigs, James B.
    Levy, Daniel
    Fox, Caroline S.
    ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (17) : 1884 - 1891
  • [33] Increased cardiovascular risk in patients with chronic kidney disease
    Vondenhoff, Sonja
    Schunk, Stefan J.
    Noels, Heidi
    HERZ, 2024, : 95 - 104
  • [34] Cardiovascular risk factors in patients with chronic kidney disease
    van der Zee, Sarina
    Baber, Usman
    Elmariah, Sammy
    Winston, Jonathan
    Fuster, Valentin
    NATURE REVIEWS CARDIOLOGY, 2009, 6 (09) : 580 - 589
  • [35] Epidemiology of cardiovascular risk in patients with chronic kidney disease
    Locatelli, F
    Pozzoni, P
    Tentori, F
    Del Vecchio, L
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 : 2 - 9
  • [36] EVALUATION OF CARDIOVASCULAR RISK IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Oueslati, I.
    Lahiani, S.
    Bouzid, K.
    Khiari, K.
    Kaaroud, H.
    Elfaleh, E.
    Bartkiz, A.
    Ben Abdallah, N.
    Abdelmoula, J.
    ATHEROSCLEROSIS, 2016, 252 : E152 - E152
  • [37] THE CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Matas, L.
    Ponte, P.
    Filella, D.
    Gusta, M.
    Sole, M.
    Ballart, J.
    Casademont, J.
    Roca-Cusachs, A.
    Arroyo, J.
    JOURNAL OF HYPERTENSION, 2015, 33 : E351 - E352
  • [38] Cardiovascular risk factors in patients with chronic kidney disease
    Sarina van der Zee
    Usman Baber
    Sammy Elmariah
    Jonathan Winston
    Valentin Fuster
    Nature Reviews Cardiology, 2009, 6 : 580 - 589
  • [39] Cardiovascular risk and lifestyle in patients with chronic kidney disease
    Fe, Erika de Moura
    de Araujo, Acucena Leal
    Carneiro Moura, Tatiana Victoria
    Melo Araujo, Dinah Alencar
    de Sousa, Valdenia Maria
    Vilarouca da Silva, Ana Roberta
    REV RENE, 2018, 19
  • [40] Cardiovascular risk prediction in chronic kidney disease patients
    Cedeno Mora, Santiago
    Goicoechea, Marian
    Torres, Esther
    Verdalles, Ursula
    Perez de Jose, Ana
    Verde, Eduardo
    Garcia de Vinuesa, Soledad
    Luno, Jose
    NEFROLOGIA, 2017, 37 (03): : 293 - 300